Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents

Fabrizio D'Ascenzo, Claudio Moretti, Matteo Bianco, Alessandro Bernardi, Salma Taha, Enrico Cerrato, Pierluigi Omedè, Antonio Montefusco, Antonio H. Frangieh, Cheol W. Lee, Gianluca Campo, Alaide Chieffo, Giorgio Quadri, Marco Pavani, Giuseppe B. Zoccai, Fiorenzo Gaita, Seung Jung Park, Antonio Colombo, Christian Templin, Thomas F. LüscherGregg W. Stone

Research output: Contribution to journalArticle

Abstract

The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention, especially in the era of second-generation drug-eluting stents (DES). The work was conducted from November 2014 to April 2015. All randomized controlled trials comparing short (

Original languageEnglish
Pages (from-to)1714-1723
Number of pages10
JournalThe American Journal of Cardiology
Volume117
Issue number11
DOIs
Publication statusPublished - Jun 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

D'Ascenzo, F., Moretti, C., Bianco, M., Bernardi, A., Taha, S., Cerrato, E., Omedè, P., Montefusco, A., Frangieh, A. H., Lee, C. W., Campo, G., Chieffo, A., Quadri, G., Pavani, M., Zoccai, G. B., Gaita, F., Park, S. J., Colombo, A., Templin, C., ... Stone, G. W. (2016). Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents. The American Journal of Cardiology, 117(11), 1714-1723. https://doi.org/10.1016/j.amjcard.2016.03.005